BofA upgraded United Therapeutics (UTHR) to Neutral from Underperform with a $314 price target Stay Ahead of the Market: Discover ...

As previously reported, BofA analyst Jason Gerberry upgraded United Therapeutics (UTHR) to Neutral from Underperform with an unchanged price ...

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life ...

RESEARCH TRIANGLE PARK, N.C., April 16, 2025--United Therapeutics Corporation (Nasdaq ... be presented at the International Society for Heart and Lung Transplantation (ISHLT) 45th Annual Meeting ...

Probably the most famous of them was Baby Faye in 1984, who lived for 21 days with a baboon’s heart. They didn’t work because ...

Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended Mar. 31, 2025. Recent Highlights. Q1 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

What a time to be alive. eVTOL developer Archer Aviation is making this dream a reality alongside its business partner, United Airlines, offering travelers to NYC a new map of air taxi routes to ...

Probably the most famous of them was Baby Faye in 1984, who lived for 21 days with a baboon’s heart. They didn ... Drug Administration has given United Therapeutics permission to do a clinical ...

Other trials are testing pig kidneys from both eGenesis and United Therapeutics in experimental transplants, the Associated Press reported.